- Home
- Articles
- latamerica
- biomarker discovery
Refine by
Biomarker Discovery Articles & Analysis
23 articles found
Applications of Transcriptome Analysis The wide application of transcriptomics in biomedical research is of great significance in understanding the basic mechanisms of life, revealing the molecular mechanisms of disease development, and discovering new therapeutic targets and drugs, including the following directions: Analysis of Gene Expression Regulation l Study the expression pattern of ...
Such investigations may lead to the discovery of novel biomarkers or therapeutic targets for kidney diseases. ...
Disease Research: By mapping altered flux patterns in cancer cells, cardiovascular diseases, or diabetes, MFA helps identify potential metabolic vulnerabilities or biomarkers for diagnosis and therapy. Agricultural Sciences: MFA can uncover mechanisms by which plants adapt to environmental stresses, aiding in crop improvement. ...
Understanding and analyzing these biomolecules has become increasingly important in areas such as disease research, biomarker discovery, and drug development. NAD and NADH are not merely passive participants in metabolism—they are regulatory molecules that influence key metabolic pathways, including glycolysis, oxidative phosphorylation, and biosynthetic ...
Furthermore, understanding the tumor microenvironment through these models can lead to the discovery of novel biomarkers, facilitating patient stratification and improving treatment decisions. ...
Gene Expression Studies: HCEC-12 allows for the examination of gene expression profiles in response to different stimuli, paving the way for biomarker discovery and understanding the genetic basis of corneal diseases. ...
Alfa Cytology has announced cancer diagnostic biomarker development services to enhance precision in oncology research. ...
Furthermore, the application of RNases in biomarker discovery offers promising avenues for diagnosing and treating a variety of conditions, offering insights into cellular responses under stress or disease pathways. ...
Monoclonal antibodies are highly specific biological molecules that are crucial in many areas like disease diagnosis, treatment, and biomarker discovery. They can trigger an immune response in the human body by recognizing and binding to specific antigens, thereby combating pathogens. ...
About Alfa Cytology Alfa Cytology is a biotech company focused on providing early discovery and development of preclinical studies. The team works closely and communicates actively to achieve their common goals of helping researchers and professionals understand PC biology, explore new PC therapeutics & protocols, and develop new PC biomarkers. ...
Dr. Kate Sasser from Tempus led a discussion on the potential of antibody-drug conjugates (ADCs), their challenges in targeting tumor antigens, and the future of cancer treatment with Dr. Daniel Johnson, Dr. Funda Meric-Bernstam, and Dr. Kellogg Parsons. The oncology field is rapidly advancing with the development of antibody-drug conjugates (ADCs), offering new hope for ...
ByTempus
DIA technology has a wide range of applications in biomedical research, disease biomarker discovery, and drug development.DIA Proteomics SequencingDIA technology systematically scans the entire mass range during mass spectrometry analysis, rather than analyzing only a few preselected ions. ...
The services tend to accelerate the discovery and optimization of molecule drugs with a strict quality control system. ...
This technology is being used to advance our understanding of tumor immunology, support immunotherapy approaches, and discover new cancer biomarkers. Applications of Luminex Technology in Oncology Research In recent years, Luminex technology has been used to profile cytokines in cancer patients, providing valuable insights into the complex interplay between the tumor and the ...
This technology is being used to advance our understanding of tumor immunology, support immunotherapy approaches, and discover new cancer biomarkers. Applications of Luminex Technology in Oncology Research In recent years, Luminex technology has been used to profile cytokines in cancer patients, providing valuable insights into the complex interplay between the tumor and the ...
Applications of DGE Analysis Disease Biomarker Discovery: Identification of DEGs between healthy and diseased tissues unveils potential diagnostic or prognostic biomarkers. These biomarkers aid in disease classification, patient stratification, and the development of targeted therapies, paving the way for precision medicine. ...
Applications of DGE Analysis Disease Biomarker Discovery: Identifying DEGs between healthy and diseased tissues reveals potential diagnostic or prognostic biomarkers. These biomarkers assist in disease classification, patient stratification, and the development of targeted therapies, thereby paving the way for precision ...
LFQ is frequently used to search tumor biomarkers in clinical studies, as tumor adjacent or normal tissues are often treated as control group. de Oliveira et al. found that MMP-7 was presented as a more promising biomarker associated with useful assays of clinical practice for gastric adenocarcinoma patient diagnosis via LFQ results. ...
RNA, not only an essential part of the central dogma, is certainly a relatively untapped resource for biomarker discovery of various diseases. Cumulating data shows that RNA molecules, including mRNAs, lncRNAs, miRNAs, siRNAs, piRNAs, snoRNAs, and snRNAs, are more sensitive and specific than protein biomarkers since they are easy to detect and ...
Introducing Beacon Biosignals: a neurotechnology company founded to develop machine learning-enabled EEG neurobiomarkers and accelerate precision medicine for any disease state affecting the brain Founded by MD/PhDs and engineers from Harvard and MIT, Beacon is propelled by the vision of a computing platform designed to scale the interrogation of large brain datasets with unprecedented ...